AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2%

Fri, 8 Nov

AJANTA PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

AJANTA PHARMA Quarterly Financials

No. of Mths Qtr. Ending		3 Sep-18*	3 Jun-19*	3 Sep-19*	QoQ Change	YoY Change
Net Sales	Rs m	5,441	6,119	6,428	5.0%	18.1%
Other income	Rs m	152	76	132	73.0%	-13.3%
Turnover	Rs m	5,594	6,196	6,560	5.9%	17.3%
Expenses	Rs m	3,779	4,436	4,651	4.9%	23.1%
Gross profit	Rs m	1,662	1,684	1,766	4.9%	6.2%
Depreciation	Rs m	175	228	233	2.3%	33.2%
Interest	Rs m	1	18	49	175.4%	3692.3%
Profit before tax	Rs m	1,638	1,515	1,616	6.7%	-1.4%
Tax	Rs m	385	368	452	22.8%	17.6%
Profit after tax	Rs m	1,254	1,146	1,164	1.5%	-7.2%
Gross profit margin	%	30.5	27.5	27.5
Effective tax rate	%	23.5	24.3	28.0
Net profit margin	%	22.4	18.5	17.7

Year-on-Year Performance:

• The company's operating income during the quarter grew 18.1% on a year-on-year (YoY) basis. The expenses were up by 23.1% YoY during the same period.
• The company's operating profit increased by 6.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 27.5% in 2QFY20 as against 30.5% in 2QFY19.
• Depreciation charges increased by 33.2% and finance costs increased by 3692.3% YoY, respectively.
• Other income declined by 13.3% YoY during the quarter.
• Net profit for the quarter declined by 7.2% YoY. Net profit margins during the quarter declined from 22.4% in 2QFY19 to 17.7% in 2QFY20.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter grew 5.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 4.9% QoQ during the same period.
• The company's operating profit increased by 4.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 27.5% in 2QFY20 as against 27.5% in 1QFY19.
• Net profit for the quarter increased by 1.5% QoQ, while net profit margins declined from 18.5% in 1QFY19 to 17.7% in 2QFY20.

To see how AJANTA PHARMA has performed over the last eight quarters,please visit here.

Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors

AJANTA PHARMA Share Price Performance

Over the last one year,AJANTA PHARMA share price has moved down from Rs 1,058.0 to Rs 996.0, registering a Loss of Rs 62.0 or around 5.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,228.6 (down 0.7%). Over the last one year it has moved down from 14,540.6 to 13,228.6, a gain of 1,312 points (down 9.0%).

Overall, the S&P BSE SENSEX is up 15.1% over the year.

Current Valuations

At the current price of Rs 996.0, the price to earnings (P/E) ratio of AJANTA PHARMA stands at 22.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.9 times.